Filing Details
- Accession Number:
- 0001415889-22-013102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-30 16:42:58
- Reporting Period:
- 2022-12-28
- Accepted Time:
- 2022-12-30 16:42:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1211583 | Fennec Pharmaceuticals Inc. | FENC | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1468308 | Robert Andrade | C/O Fennec Pharmaceuticals, Inc. Po Box 13628, 68 Tw Alexander Drive Research Triangle Park NC 27709 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2022-12-28 | 11,000 | $9.61 | 160,721 | No | 4 | S | Direct | |
| Common Shares | Disposition | 2022-12-29 | 5,500 | $9.57 | 155,221 | No | 4 | S | Direct | |
| Common Shares | Disposition | 2022-12-30 | 5,500 | $9.61 | 149,721 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares sold pursuant to a 10b5-1 plan on December 28, 2022.
- Represents shares sold pursuant to a 10b5-1 plan on December 29, 2022.
- Represents shares sold pursuant to a 10b5-1 plan on December 30, 2022.
Billionaire Hedge Funds
